cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Annexon Inc
5 own
7 watching
Current Price
$4.83
$-0.01
(-0.21%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
865.46M
52-Week High
52-Week High
8.40000
52-Week Low
52-Week Low
3.86000
Average Volume
Average Volume
1.72M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization865.46M
icon52-Week High8.40000
icon52-Week Low3.86000
iconAverage Volume1.72M
iconDividend Yield--
iconP/E Ratio--
What does the Annexon Inc do?
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company s C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated neurodegeneration. Its product candidates include ANX005, a monoclonal antibody, which is in Phase II/III clinical trials to treat patients with guillain- barré syndrome; Phase II trial in patients with warm autoimmune hemolytic anemia; and Phase II clinical trial for Huntington's disease and amyotrophic lateral sclerosis. The company is also developing ANX009 that is in Phase Ib trial in patients with lupus nephritis; and ANX007, which is in Phase II clinical trials to treat patients with geographic atrophy. In addition, it develops ANX105, an investigational monoclonal antibody targeting neurodegenerative indications; and ANX1502, an investigational oral small molecule for the treatment of certain autoimmune indications. The company was incorporated in 2011 and is headquartered in Brisbane, California.
Read More
How much money does Annexon Inc make?
News & Events about Annexon Inc.
Zolmax
1 year ago
Needham & Company LLC restated their buy rating on shares of Annexon (NASDAQ:ANNX Get Rating) in a research report sent to investors on Tuesday , Benzinga reports. The firm currently has a $24.00 target price on the stock. Separately, HC Wainwright restated a buy rating and issued a $30.00 target ...
Ticker Report
1 year ago
HC Wainwright reaffirmed their buy rating on shares of Annexon (NASDAQ:ANNX Get Rating) in a research note released on Tuesday, Benzinga reports. The brokerage currently has a $30.00 price objective on the stock. HC Wainwright also issued estimates for Annexons Q1 2023 earnings at ($0...
Market News Video
1 year ago
In trading on Monday, shares of Annexon Inc (ANNX) crossed below their 200 day moving average of 5.23, changing hands as low as 5.10 per share. Annexon Inc shares are currently trading down about 2.2% on the day...
Zolmax
2years ago
Annexon, Inc. (NASDAQ:ANNX Get Rating) Equities researchers at Jefferies Financial Group issued their FY2027 earnings per share estimates for shares of Annexon in a report released on Tuesday, January 10th. Jefferies Financial Group analyst S. Jeong forecasts that the company will post earnings of...
Globe Newswire
2years ago
Mid-stage and Pivotal Trials of ANX005, ANX007 and ANX1502 Poised to Achieve Numerous Catalysts in Multiple Disease Indications Well-Capitalized with Operating Runway into 2025 Company to Present Pipeline Updates at 41st Annual J.P. Morgan Healthcare Conferenceon January 11, 2023, at 7:30 a.m. PT ...
Frequently Asked Questions
Frequently Asked Questions
What is Annexon Inc share price today?
plus_minus_icon
Can Indians buy Annexon Inc shares?
plus_minus_icon
How can I buy Annexon Inc shares from India?
plus_minus_icon
Can Fractional shares of Annexon Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Annexon Inc stocks?
plus_minus_icon
What is today’s traded volume of Annexon Inc?
plus_minus_icon
What is today’s market capitalisation of Annexon Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Annexon Inc?
plus_minus_icon
What percentage is Annexon Inc down from its 52-Week High?
plus_minus_icon
What percentage is Annexon Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$4.83
$-0.01
(-0.21%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
OLEMA PHARMACEUTICALS INC
OLEMA PHARMACEUTICALS INC
$5.04
$-0.71 (-12.35 %)
ARCUTIS BIOTHERAPEUTICS INC
ARCUTIS BIOTHERAPEUTICS INC
$13.81
$-1.46 (-9.56 %)
89bio Inc
89bio Inc
$6.51
$-0.84 (-11.43 %)
4D Molecular Therapeutics Inc
4D Molecular Therapeutics Inc
$5.52
$-0.32 (-5.48 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
OLEMA PHARMACEUTICALS INC
OLEMA PHARMACEUTICALS INC
$5.04
$-0.71 (-12.35 %)
ARCUTIS BIOTHERAPEUTICS INC
ARCUTIS BIOTHERAPEUTICS INC
$13.81
$-1.46 (-9.56 %)
89bio Inc
89bio Inc
$6.51
$-0.84 (-11.43 %)
4D Molecular Therapeutics Inc
4D Molecular Therapeutics Inc
$5.52
$-0.32 (-5.48 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00